In summary, enhanced TX-dependent platelet activation is a typical phenomenon in T2DM patients and is associated with oxidative stress, a proinflammatory state, hyperglycemia, and insulin resistance, which may contribute to hypofibrinolysis, at least in part through enhanced release of PAI-1 and PMP. This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.